What the research shows 15% Visceral fat reduction over 26 weeks (Tesamorelin, Phase III) 2 pathways GHRH + ghrelin, dual GH stimulation FDA-approved Tesamorelin component, for visceral-fat reduction 12 mo Trunk-fat & triglyceride benefits sustained over a year (study) Our medication is delivered from a state-licensed pharmacy in our network, right to your door when you need it
Journal of Dermatology & Dermatologic Surgery , 23(4), 41-47
doi: 10.3389/fphar.2020.592985 482 FahmiAAEl RaeyMAIbrahimAYAbdelfattahMAAbdelmageedAMSobehM
A similar upregulation in striatal levels of GSTO2 was observed during the presymptomatic phase, concomitant with BDNF downregulation before the increases in dopamine
Reconstitution technique and sterility Contamination during mixing shortens shelf life dramatically
Increasing growth hormone can be a powerful part of an anti-aging therapy strategy